It is difficult to assess the likelihood of perioperative cardiac events mainly because of complicated interrelationships between clinical risk and type of surgery. To overcome this problem, The American College of Cardiology/American Heart Association（ACC/AHA）Task Force published guidelines for perioperative cardiovascular evaluation for non-cardiac surgery. The guidelines offer the strategy of preoperative cardiac therapy, operative performance and perioperative management depending on the urgency of surgery, the patient s risk factors, findings of cardiac testing and specific surgical considerations. Non-invasive cardiac testing including myocardial perfusion single-photon emission computed tomography（SPECT）is recommended to be used mainly in patients with poor functional capacity, when the results will affect patient treatment and outcomes. In the current review, we summarized the use of stress myocardial perfusion SPECT referring to previous reports and our data, and provided the tips for indication of SPECT in preoperative risk stratification in non-cardiac surgery. In the current review, we summarized the use of stress myocardial perfusion single-photon emission computed tomography（SPECT）referring to previous reports and our data, and provided the tips for indication of SPECT in preoperative risk stratification in non-cardiac surgery.
Since it is generally difficult to perform a prospective clinical trial for assessing the predictive value on patients undergoing surgery especially when the test results are blinded, most studies of this kind is retrospective. In such studies, authors analyzed the data obtained from patients who underwent preoperative SPECT. Most of them were referred for SPECT because of concern about perioperative cardiac risk. Thus, these patients do not epitomize the general population of noncardiac surgery candidates in terms of the likelihood of cardiac events. This increases the rate of perioperative cardiac events.
Furthermore, the effect of preoperative revascularization remains unclear. There are some papers showing that preoperative revascularization is ineffective to reduce the cardiac event rate（8,9） . However, the effect of preoperative revascularization depends on the selection of patients undergoing revascularization.
Further studies are required to clarify the usefulness of SPECT in identifying patients who receive prognostic benefit from preoperative revascularization.
It is generally difficult to elucidate the cost-effectiveness of perioperative SPECT, because of relatively low frequency of perioperative cardiac events, high cost of examination and uncertainty of the effect of preoperative revascularization as mentioned above.
SPECT in preoperative risk stratification
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Risk of surgical procedures
As indicated in Table 1 patients with a high estimated cardiac risk, because such data show that cardiac risk is reduced by such choices. We showed that gated myocardial perfusion SPECT has an incremental prognostic value in intermediate, but not in low-risk, non-cardiac surgery as indicated in Fig. 2（6） . : unstable coronary disease, decompensated heart failure, significant arrhythmia and severe valvular heart disease, ＊＊ : indicated in Table 1 , ＊＊＊ : diabetes mellitus, renal insufficiency, and the history of ischemic heart disease, heart failure, or cerebrovascular disease. closed bar,（A）summed rest score＞7,（B）summed stress score＞9,（C）and（D）LVEF＜45%; hatched bar,（A） 1＜summed rest score＜6,（B）1＜summed stress score＜8,（C）and（D）46%＜LVEF＜59%; unfilled bar,（A） summed rest score＝0,（B）summed stress score＝0,（C）and（D）LVEF＞60%; ＊ . p＜0.05; ＊＊ , p＜0.01（comparison between the unfilled bar and others） .
The total numbers of patients are 1220 in（A）and（B） , and 868 in（C）and（D） . The threshold values（summed stress score＝9. Furthermore, it remains unclear whether the cause of increased perioperative cardiac risk is attributable to aging itself or to the associated cardiac risk factors and coronary disease. In our previous report（11） , we divided patients into different groups according to the age and SPECT findings to separate the influence of aging from that of associated coronary artery disease.
As indicated in Fig. 3 , aging itself had no appreciable influence on perioperative cardiac risk in patients with normal myocardial perfusion. In contrast, in patients with perfusion abnormality, cardiac event rate increases following aging, independently of other clinical variables.
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The prevalence of CAD is reported to be high in The event rate increased depending on surgical risk when patients manifested abnormal perfusion findings, while such tendency was not observed in patients with normal perfusion.（cited from reference No. 12） The numbers in parentheses are the number of patients with cardiac events/total number in the category.
